CoChat

The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe

The DOI matches its Crossref record; 86 of the 87 references it cites were found in a registry or an index.

Abstract

Recent progress in the research of mesenchymal stromal cells/multipotent stromal cells (MSC) has revealed numerous beneficial innate characteristics, suggesting potential value in an array of cellular therapies. MSC are easily isolated from bone marrow (BM), fat and other tissues, and are readily propagated in vitro. Transplanted/injected MSC have been shown to migrate to a variety of organs and tissues; however, sites of inflammation and pathology elicit enhanced MSC homing for tissue remodeling and repair. Tumors utilize many of the same inflammatory mediators uncovered in wound healing and likewise provide a site for preferential MSC homing. Although incorporation into the tumor microenvironment is apparent, the role of recruited MSC in the tumor microenvironment remains unclear. Some published studies have shown enhancement of tumor growth and development, perhaps through immunomodulatory and pro-angiogenic properties, while others have shown no apparent effect or have demonstrated inhibition of tumor growth and extended survival. This controversy remains at the forefront as clinical applications of MSC commence in anti-tumor therapies as well as as adjuncts to stem cell transplantation and in ameliorating graft-versus-host disease. Careful analysis of past studies and thoughtful design of future experiments will help to resolve the discrepancies in the field and lead to clinical utility of MSC in disease treatment. This review highlights the current theories of the role…

Overview

Integrity signals

Registry

Crossref · 10.1080/14653240802486517

Cites

86 of 86 references verified0 citation errors · 0 not checkable

Statistics

Recomputing p-values needs the paper’s full text.

Verification

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Citations

Cites

Show all 86 references

Research works printed but not linked: 2

  1. Bolontrade, 2003, Bone marrow side population cells contribute to neovessel formation in Ewing's sarcoma, Stem Cell Cellular Ther, 1, 14
  2. Emura, 2000, Development of myofibroblasts from human bone marrow mesenchymal stem cells cocultured with human colon carcinoma cells and TGF beta 1, In Vitro Cell Dev Biol Anim, 36, 77, 10.1290/1071-2690(2000)036 · doi:10.1290/1071-2690(2000)036

Cited by

See all 131

Metadata

Authors
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F.
Affiliations
  • The University of Texas MD Anderson Cancer Center (US)
  • Abigail Wexner Research Institute (US)
Corresponding author
Marini, Fc
Venue
Cytotherapy
Publisher
Elsevier BV
Published
2008
Volume
10
Issue
7
Pages
657-667
ISSN
1465-3249 (ISSN-L)
OpenAlex
W2161768378
Cited by
128
References
87
Citations by year
2025: 2 · 2024: 1 · 2023: 4 · 2022: 2 · 2021: 2 · 2020: 1 · 2019: 5 · 2018: 6 · 2017: 3 · 2016: 7 · 2015: 7 · 2014: 10 · 2013: 10 · 2012: 20
FWCI
1.69
Type
journal article
Language
en
Open access
closed
Licence
  • www.elsevier.com/tdm/userlicense/1.0/ (tdm)
  • www.elsevier.com/legal/tdmrep-license (tdm)
Locations
  • Cytotherapy (publishedVersion)
  • PubMed (publishedVersion)
Funders
National Cancer Institute (P50CA116199, CA-16672, CA-55164, CA-1094551, R01CA109451, P01CA049639, P01CA055164, Ca-116199, P30CA016672, CA 49639)
Topics
  • Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Mesenchymal stem cell research
  • Health Sciences › Medicine › Oncology › Cancer Cells and Metastasis
  • Life Sciences › Immunology and Microbiology › Immunology › Immune cells in cancer
Keywords
mesenchymal stem cells, tumor microenvironment, tumor growth, immunomodulation, angiogenesis, inflammation, anti-tumor therapy, graft-versus-host disease, stem cell transplantation, bone marrow, adipose tissue
MeSH terms
Animals, Humans, Neoplasms, Wound Healing, Stromal Cells, Mesenchymal Stem Cell Transplantation, Mice, Mesenchymal Stem Cells

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. https://app.cochat.ai/papers/10.1080/14653240802486517
The paper
Kidd, S., Spaeth, E., Klopp, A., Andreeff, M., Hall, B., & Marini, F. (2008). The (in) auspicious role of mesenchymal stromal cells in cancer: be it friend or foe. Cytotherapy. https://doi.org/10.1080/14653240802486517

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.